Revian Announces Amy Keish Joins Company as Vice President of Healthcare Sales
2024-04-04
高管变更
MORRISVILLE, N.C., April 4, 2024 /PRNewswire/ -- REVIAN Inc., an aesthetic medical technology company using precise wavelengths of LED light to rejuvenate hair and skin, announced today that Amy Keish will be joining the Company as Vice President of Healthcare Sales. Ms. Keish brings more than 18 years of industry experience in the hair restoration market, most recently serving as the National Director of Senior Counselors for Bosley.
"I am thrilled to join the Revian team and help bring relief for those suffering from Androgenetic Alopecia. The Revian Red system's differentiated attributes make it ideal for not only single mode therapy but also multi modal therapies which position it to continue to take advantage of the significant growth the market is seeing. Revian's unique benefits to women make this a particularly exciting opportunity."
Ms. Keish graduated from Elon University and began her career in hair restoration at The Hair Club, ultimately progressing to Regional Director, before she joined Bosley as the National Director of Senior Counselors. She will work with Tim Waite who is continuing with the company in his sales capacity.
About the Revian Red Hair Growth System
The award winning REVIAN RED System is an FDA cleared, lightweight wireless cap controlled by a mobile App that functions to provide a hair loss treatment for men and women using precision LED light. The device's patented dual wavelength LED technology provides broader scalp coverage and better skin penetration than red lasers traditionally used in low level light therapy (LLLT) producing the best clinical trial performance of any hair rejuvenation treatment available on the market. REVIAN RED uses a patented combination of two wavelengths of LED light to stimulate the production and release of nitric oxide, proven to increase local blood flow, reduce inflammation, and inhibit DHT production which provides the right environment for new hair growth. REVIAN RED's cleared indication for use is the treatment of androgenetic alopecia, to promote hair growth in males who have Norwood-Hamilton classifications of IIa-V patterns of hair loss and to treat androgenetic alopecia and promote hair growth in females who have Ludwig-Savin Scale I-1 to II-4, II1, II2 or frontal patterns of hair loss; both with Fitzpatrick Skin Types I-IV.
About Revian, Inc.
Revian, an operating subsidiary of KNOW Bio, LLC, is an aesthetic medical technology innovator dedicated to stimulating the body's natural processes to rejuvenate hair and skin with light. The company creates products that precisely deliver light and allow people to experience its regenerative potential in the convenience of their own homes. Revian is committed to partnering with health-care providers and other caring professionals to deliver meaningful results, backed by scientific data. For more information, visit www.revian.com.
Contact:
John Oakley
[email protected]
919-939-7715
SOURCE REVIAN, Inc.
更多内容，请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。
靶点
-药物
-热门报告
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台，助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台，以API或者数据包形式对外开放，助您更加充分利用智慧芽新药情报信息。